IGCS 2025 Education Session 01: Molecular Oncology
Education session presented at IGCS 2026 in Cape Town, South Africa
IGCS 2025 Education Session 01: Molecular Oncology

This session will provide a practical overview of molecular diagnostics in gynecologic oncology, focusing on the rationale behind key tests like IHC, FISH, and NGS. Through tumor-specific talks on ovarian, endometrial, cervical, and vulvar cancers, we’ll explore how molecular results inform diagnosis, prognosis, and treatment decisions in real-world clinical contexts. 

 

Chair Stephanie Lheureux (Canada)
Why We Test: The Role of Molecular Diagnostics in Gynecologic Oncology – Navigating Diagnosis, Prognosis, and Treatment 

 

Decoding Ovarian Cancer: BRCA, HRD, and Beyond – Who to Test, and Why It Matters  Ainhoa Madariaga (Spain)
Molecular Stratification and New Treatment Directions in Endometrial Cancer   Stephanie Lheureux (Canada)
Biomarkers in Cervical and Vulvar Cancers  Paul Cohen (Australia)
Panel Discussion and Q&A    
Summary
Availability:
On-Demand
Cost:
FREE